Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Semaglutide seems beneficial for comorbid T2DM, tobacco use disorder
Jul 29, 2024
A lower risk for medical encounters for a tobacco use disorder diagnosis was seen in association with semaglutide versus other antidiabetes meds.
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
Long-term care pharmacies forced to borrow to buy resident drugs, close as intermediaries tighten grip...
By
Kimberly Marselas
Apr 08, 2024
Long-term care resident access to prescription drugs is being squeezed as several market and regulatory factors have combined to increase the power that pharmacy benefit managers have over the specialized...
Legislation aims to ensure ‘fair and accurate’ Alzheimer’s treatment coverage decisions
By
Kimberly Bonvissuto
Nov 21, 2023
Federal legislation that would prevent the federal government from imposing wide-reaching coverage restrictions on Alzheimer’s treatments was reintroduced last week, providing “fair and accurate”...
Methotrexate beneficial for reducing pain, stiffness in knee osteoarthritis
Jul 31, 2024
Significant pain reduction was seen in favor of methotrexate; stiffness and function improved at six months.
Feds’ antipsychotic drug reduction efforts in assisted living fail to produce success seen in nursing...
By
Alicia Lasek
Aug 23, 2022
A federal initiative to reduce antipsychotic prescribing in long-term care facilities failed to impact prescriptions in assisted living residents with dementia, the first study of its kind has found.
Nasal sprays, behavioral intervention aid in treatment of respiratory illness
Jul 30, 2024
The use of a gel-based spray or saline spray reduced the duration of illness, whereas all interventions cut antibiotic use.
Suicidal ideation, behaviors not increased with GLP-1 RAs for seniors with T2D
Jul 16, 2024
No significant increase was seen with the use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries.